Re: Watchdog (Pharmalot Blog) example of bedfellows

[Guest guest]

Wow. Can't belive the conflict of interest on the oversight board!!! Yes, we need to start a list of all interested parties. Carol Chittenden

The project on government oversight....

I think we must send them a copy of the report you are compiling Carol...

I think we need to make it painfully clear that an oversight board was convened in 2009 with a pediatric neurologist on the board and that they 'came to no conclusive evidence'

regarding effects of Miralax and additional products known by different names.

We need to make them aware we will not accept another board ruling like that.

We need to have public citizens on the board and I for one, am willing to pay my own way and do what is necessary to be part of the process.

Do we need to go 'picket' the FDA office?

Way too much nepotism taking place and hundreds of millions of dollars at stake... All while our children are the victims...not to mention the unsuspecting adults!

This is over the counter, no one thinks it is dangerous!!!!!!!!

Until.........

The worst happens

and everyones' lives are changed forever.................

Watchdog Calls for New Yaz Meeting (Pharmalot Blog)

The Project On Government Oversight, a government watchdog group, has written FDA Commissioner Margaret Hamburg requesting a new advisory committee convene to review the safety of Bayer’s Yaz and Yasmin birth control pills. The panel that met last month voted 15-11that the benefits outweigh the risks, blogger Ed Silverman writes, but four of the 26 panelists that voted had ties to the drugmaker. “The episode underscores ongoing concern over agency handling of advisory panels and conflicted members,†Silverman writes. In recent months, agency officials and even Hamburg herself “have complained about a paucity of qualified experts to serve on panels who do not hold some type of conflict in a bid to loosen regulations,†Silverman adds. Meanwhile, panel vacancy rates have remained low and conflict of interest waivers granted have remained below target,†suggesting the agency is not having as much difficulty finding qualified experts as officials maintain,†Silverman writes.

PUBLISHER'S NOTE: Some of the news agencies sourced within the Drug World Daily section may require subscriptions to access their information. At the time of transmission, all links to news articles functioned, but FDAnews cannot guarantee the accuracy of the information or that the listed news agencies will not move or delete information.

Too many people all in 'bed' with each other!

Can we even trust the FDA anymore?

Poly-ethylene glycol

should have been removed from the market in 2009.

The only way doctors will stop giving it to children, is if it is no longer available.

That should be our argument.